Bersanlimab clinical trials
Also written BI-505.
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2009
How each study uses bersanlimab is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- BI-505
- 3
Studies by the year they started
3 studies that test it; most in 2009 (1)
| Year | Studies |
|---|---|
| 2009 | 1 |
| 2013 | 1 |
| 2016 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 0
BioInvent International AB (3)
Studies
Open first, then newest update. How each study uses bersanlimab is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- A Phase II Study of BI-505 in Smoldering Multiple MyelomaTerminatedPhase 2BioInvent International ABNCT01838369Written as BI-505How we know
- A Phase I/II Study of BI-505 in Conjunction With Autologous Stem Cell Transplant in Multiple MyelomaTerminatedPhase 1/2BioInvent International ABNCT02756728Written as BI-505How we know
- A Study of a Human Anti-Intercellular Adhesion Molecule-1 Monoclonal Antibody, in Patients With Multiple MyelomaCompletedPhase 1BioInvent International ABNCT01025206Written as BI-505How we know
Codes
What other systems call bersanlimab · ClinicalTrials.gg INT017316
- UNII (FDA) MP3N1L4OR6BERSANLIMABOne source FDA
- NCI Thesaurus C88327BersanlimabOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | MP3N1L4OR6 | BERSANLIMAB | One source FDA |
| NCI Thesaurus | C88327 | Bersanlimab | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.